LDLR rs121918406: Understanding This Rare Genetic Variant
The rs121918406 variant is a rare genetic alteration located within the LDLR gene. It is recognized in clinical literature as a pathogenic mutation associated with familial hypercholesterolemia, a condition characterized by significantly elevated levels of low-density lipoprotein (LDL) cholesterol.
What each genotype means
Typical LDLR function
This genotype represents the common, non-pathogenic sequence at this position in the LDLR gene. Individuals with this genotype do not carry the specific pathogenic mutation associated with this variant record.
This is the most common genotype found in the general population.
Reduced LDLR activity
This genotype indicates the presence of one copy of the pathogenic c.670G>A (p.Asp224Asn) variant. Research indicates this mutation can lead to reduced low-density lipoprotein receptor activity, which is associated with familial hypercholesterolemia. Please discuss your lipid profile and any necessary clinical management with your healthcare provider.
This specific pathogenic variant is rare in the general population.
Significantly reduced LDLR activity
This genotype indicates the presence of two copies of the pathogenic c.670G>A (p.Asp224Asn) variant. This state is associated with a more severe reduction in LDLR function and a higher risk for familial hypercholesterolemia phenotypes. It is essential to consult with a cardiologist or lipid specialist to discuss appropriate clinical monitoring and management.
This homozygous genotype is extremely rare in the general population.
What is rs121918406?
The rs121918406 variant is a specific change in the DNA sequence of the LDLR gene. In genetics, a variant like this represents a deviation from the most common sequence found in the human population. Because it is located within a gene that provides critical instructions for cholesterol management, researchers monitor such variants to understand how they might disrupt normal biological processes. This specific variant is classified as rare, meaning it is not commonly found in the general population. When a variant is identified as pathogenic, it suggests that the change in the genetic code can lead to a loss of function or altered function in the protein the gene is responsible for creating. Scientists use databases like ClinVar to track these variants and their clinical significance, helping to bridge the gap between raw genetic data and observable health outcomes.
The Role of the LDLR Gene
The LDLR gene provides the blueprint for the low-density lipoprotein receptor (LDLR) protein. This protein acts like a molecular gatekeeper on the surface of cells, particularly in the liver. Its primary job is to bind to LDL particles—often called 'bad' cholesterol—circulating in the bloodstream and pull them into the cell to be broken down. This process is essential for maintaining healthy cholesterol levels in the blood. When the LDLR gene contains a pathogenic variant, the resulting receptor may be missing, malformed, or unable to bind to LDL effectively. As a result, LDL cholesterol remains in the bloodstream at abnormally high levels. This accumulation is a hallmark of familial hypercholesterolemia, a condition that can lead to the early development of cardiovascular issues if not managed appropriately through medical intervention.
Research and Clinical Evidence
Research into rs121918406 is grounded in its association with familial hypercholesterolemia. Clinical studies often identify such variants in individuals who present with severe, early-onset cholesterol elevations that do not respond well to standard lifestyle modifications alone. The evidence for this variant's pathogenicity is considered moderate to strong within the context of clinical genetics, as it is frequently identified in patients with clear clinical symptoms of the disorder. It is important to note that genetic research is an evolving field; while we understand the mechanism of the LDLR gene, the specific impact of any single variant can vary based on an individual's overall genetic background and environmental factors. Clinical researchers continue to study these variants to improve diagnostic accuracy and to better understand the spectrum of severity in cholesterol-related metabolic disorders.
Population Frequency
The rs121918406 variant is categorized as rare across global populations. Because it is not a common polymorphism, it is not typically found in the vast majority of individuals. Its presence is usually identified through targeted genetic testing in clinical settings, particularly when a patient or their family members exhibit signs of familial hypercholesterolemia. Because the variant is rare, large-scale population studies often show very low or negligible frequencies, which is expected for variants that have a significant impact on health. The rarity of this variant underscores why it is not included in standard, broad-spectrum wellness genetic tests and why its identification is usually the result of a focused diagnostic investigation by a healthcare provider.
Managing Genetic Information
If you have received information about this variant, it is essential to understand that this is not a medical diagnosis. Genetic variants are only one piece of a complex puzzle that includes your diet, lifestyle, and other genetic factors. You cannot 'fix' a genetic variant, but you can manage the health outcomes associated with it. If you are concerned about your cholesterol levels or your family history, the most important step is to consult with a physician, a cardiologist, or a genetic counselor. They can interpret your results in the context of your overall health and discuss appropriate screening or management strategies. Never make changes to your medication or health regimen based on genetic data without professional guidance. Your healthcare team is equipped to provide personalized advice based on current clinical guidelines and your specific medical history.
How common is this variant?
The rs121918406 variant is considered rare in the general population, with very low frequency across all major ancestral groups.
Frequently asked questions
Is rs121918406 a diagnosis for high cholesterol?
No, identifying a genetic variant is not a medical diagnosis. While this variant is associated with familial hypercholesterolemia, a doctor must evaluate your actual blood cholesterol levels and clinical history to make a diagnosis.
Should I be worried if I have this variant?
Finding a rare variant can be concerning, but it is important to discuss the results with a healthcare professional. They can help you understand what this means for your specific health profile and whether any additional monitoring is necessary.
Can I change my genes if I have this variant?
You cannot change your genetic code. However, knowing about a genetic predisposition allows you and your doctor to implement proactive management strategies, such as specialized diets or medications, to help maintain healthy cholesterol levels.
Where can I get more information on LDLR variants?
Reliable sources include MedlinePlus Genetics, the ClinVar database, and professional medical organizations like the American Heart Association. Always prioritize information from peer-reviewed medical and scientific institutions.
Sources & further reading
Educational information only, last refreshed 10/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121918406?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in LDLR
Pathogenic missense variant altering low-density lipoprotein receptor function and predisposing to severe familial hypercholesterolemia.
This pathogenic variant in the LDLR gene is a contributor to familial hypercholesterolemia, leading to significantly elevated LDL cholesterol levels.
Variant in the LDLR 3' UTR region associated with statin efficacy, often studied in East Asian cohorts.
A variant in the 3' UTR of the LDLR gene associated with variations in statin therapeutic response.
Synonymous variant in the LDLR gene associated with plasma LDL cholesterol levels.
This variant is a well-established marker associated with LDL cholesterol levels and risk of coronary artery disease.
